Protein Kinases as Drug Development Targets for Heart Disease Therapy - sprookjes - yvandenbroek - TriplyDB

Protein Kinases as Drug Development Targets for Heart Disease Therapy

Protein Kinases as Drug Development Targets for Heart Disease Therapy

http://www.wikidata.org/entity/Q33678033

about

Regulation of CaMKII signaling in cardiovascular disease KinMap: a web-based tool for interactive navigation through human kinome data Pseudokinases: update on their functions and evaluation as new drug targets.In Vivo Protective Effects of Diosgenin against Doxorubicin-Induced Cardiotoxicity.Mitogen-activated protein kinase signaling and its association with oxidative stress and apoptosis in lead-exposed hepatocytes.Cyclic Nucleotide-Directed Protein Kinases in Cardiovascular Inflammation and Growth.Breakthroughs in modern cancer therapy and elusive cardiotoxicity: Critical research-practice gaps, challenges, and insights.Protein tyrosine phosphatases in cardiac physiology and pathophysiology.Suppression of phosphorylated MAPK and caspase 3 by carbon dioxide.The Akt pathway in oncology therapy and beyond (Review)

P2860

Q26785302-FCDAA4BD-2903-4BFE-BDD6-96930D9A8D7D Q28583683-729C27FF-A2A6-413D-BDFA-5765FF12451A Q30397636-00C258E2-B3B9-4EC3-89F7-9CC1884E477F Q35809052-8266694C-85F6-4FFA-8DFC-646DC4FA820E Q42708115-C9EC64D1-B95B-4D98-9C85-BD61F05CDE70 Q47713533-330B9E72-7B4F-423F-9566-45E2A4FB21DF Q49315568-2A412AC6-14E7-4F7E-9C85-510AB7E6291E Q49356041-899D0EF5-1C70-4CEE-94E8-560973EAD96D Q50972454-14395D47-D5BD-40C5-897E-5C8F3ACC4BB2 Q58555910-C647E9E5-EF4C-4E6E-B8CE-1DEA5B5542A9

P2860

Protein Kinases as Drug Development Targets for Heart Disease Therapy

http://www.wikidata.org/entity/Q33678033

description

2010 nî lūn-bûn

@nan

2010 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Protein Kinases as Drug Development Targets for Heart Disease Therapy

@ast

Protein Kinases as Drug Development Targets for Heart Disease Therapy

@en

type

label

Protein Kinases as Drug Development Targets for Heart Disease Therapy

@ast

Protein Kinases as Drug Development Targets for Heart Disease Therapy

@en

prefLabel

Protein Kinases as Drug Development Targets for Heart Disease Therapy

@ast

Protein Kinases as Drug Development Targets for Heart Disease Therapy

@en

P1433

Q33678033-55BAE033-645C-471C-955A-72D9FABF9C35

P1476

Q33678033-9E59C9EF-CCFF-4349-B32D-6130B5505A89

P2093

Q33678033-4271571A-EB86-4B2F-AFF7-7D79417619B4

Q33678033-4ABDC729-7C14-43A1-B871-68DA2A23205C

P2860

Q33678033-003017FC-DB98-4392-8ABD-1F7038B619C2

Q33678033-00791317-5C0F-44F0-8361-B2B84D8A9B77

Q33678033-0380A4E7-08D2-407F-B408-4EABFF7B4B1F

Q33678033-0691E7B8-50CA-458D-B6F5-BA923514AB48

Q33678033-06DD899B-2AC2-4131-9014-53D720AFAD5D

Q33678033-07A25EBA-6279-4C36-9012-ECAAEEB7C831

Q33678033-09CE8941-9E4B-4FD3-A8F1-D14D3304A8D3

Q33678033-0B311F0E-DB88-4256-9320-3AFC107EA4D1

Q33678033-0C0CDEA8-AC33-4FE6-819E-6CAC30997B0C

Q33678033-0F2858D8-6413-4EDB-A070-25C91ACDE0F6

P304

Q33678033-DFCDBA78-CD64-4C11-94E5-FDA2FC644397

P31

Q33678033-DBFBD022-9014-4647-8072-5373B058215E

P356

Q33678033-AE1D77C8-C9B8-45B7-97A6-60ED7BAA50F1

P433

Q33678033-480EF4C3-97DC-45F7-ADC5-5AD2F8AF0F82

P478

Q33678033-784511B4-0E39-4B5F-8EFD-081AB569AF46

P577

Q33678033-7B321CD9-9975-408C-B6C8-45949C819EAB

P5875

Q33678033-7A9C91AE-9BC0-4F1B-B9FB-55602346A155

P698

Q33678033-1AFA8DE0-95C7-4835-BAFB-B80C47593AB4

P932

Q33678033-1D34930B-32FC-4AD1-94C3-E768E32FD30C

P356

P1433

Pharmaceuticals

P1476

Protein Kinases as Drug Development Targets for Heart Disease Therapy

@en

P2093

Alison L Müller

http://www.w3.org/2001/XMLSchema#string

Naranjan S Dhalla

http://www.w3.org/2001/XMLSchema#string

P2860

Protein kinase Calpha negatively regulates systolic and diastolic function in pathological hypertrophy

Purification and characterization of phosphoinositide 3-kinase from rat liver

Role of Ca2+/calmodulin-dependent protein kinase (CaMK) in excitation-contraction coupling in the heart

The extended protein kinase C superfamily

A pharmacological map of the PI3-K family defines a role for p110alpha in insulin signaling

Structural features of Ca2+/calmodulin-dependent protein kinase II revealed by electron microscopy

Cardiotrophic effects of protein kinase C epsilon: analysis by in vivo modulation of PKCepsilon translocation

AKT/PKB and other D3 phosphoinositide-regulated kinases: kinase activation by phosphoinositide-dependent phosphorylation

Neuronal CA2+/calmodulin-dependent protein kinase II: the role of structure and autoregulation in cellular function

Ca(2+)/CaM-dependent kinases: from activation to function

P304

2111-2145

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3390/PH3072111

http://www.w3.org/2001/XMLSchema#string

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

3

http://www.w3.org/2001/XMLSchema#string

P577

2010-07-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

45267146

http://www.w3.org/2001/XMLSchema#string

P698

27713345

http://www.w3.org/2001/XMLSchema#string

P932

4036665

http://www.w3.org/2001/XMLSchema#string